Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

21. Mai 2026 05:11 ET | Quelle: Research and Markets

Next Generation Immune Checkpoint Inhibitors Market Report 2026-2035: Pipeline Features ~475 Therapy Programs, Emphasizing on Enhanced Pathway Modulation to Deliver Sustained Therapeutics in Oncology

Dublin, May 21, 2026 (GLOBE NEWSWIRE) -- The "Next Generation Immune Checkpoint Inhibitors Market (2nd Edition), by Target Immune Checkpoint, Target Disease Indication, Type of Molecule,...
15. Mai 2026 07:39 ET | Quelle: Research and Markets

Tetraspecific Antibodies Clinical Pipeline Market research 2026: Development Technologies, Therapeutic Approaches & Market Opportunity Insight to 2032

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Tetraspecific Antibodies Clinical Pipeline, Development Technologies, Therapeutic Approaches & Market Opportunity Insight 2026" report has been...
14. Mai 2026 09:40 ET | Quelle: Research and Markets

Glypican-3 (GPC3) Targeted Therapy Pipeline Competitor Analysis Report 2026: Active R&D Programs by R&D Phase and Profile of Targeted Immunotherapies by Drug Modality

Dublin, May 14, 2026 (GLOBE NEWSWIRE) -- The "Glypican-3 (GPC3) Targeted Therapy: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence...
20. April 2026 12:22 ET | Quelle: Research and Markets

Immune Checkpoint Inhibitors Market Report 2026-2030 with Detailed Company Profiles, Grant Analyses, Partnership Evaluations and More

Dublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors Market: Industry Trends and Global Forecasts, till 2030" has been added to ResearchAndMarkets.com's offering. The...
20. Februar 2026 10:56 ET | Quelle: Research and Markets

Glypican-3 (GPC3) Targeted Therapy Market Competitor Analysis Report 2026: More Than 20 Product Candidates are in Clinical Development and Further Eight at IND or IND-enabling Stage

Dublin, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The "Glypican-3 (GPC3) Targeted Therapy: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence...
18. Februar 2026 10:47 ET | Quelle: Research and Markets

TIGIT Inhibitors Competitive Landscape Research Report 2026: Comprehensive Insights About 18+ Companies and 20+ Drugs

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "TIGIT Inhibitors - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report presents in-depth insights into...
10. Februar 2026 04:06 ET | Quelle: Research and Markets

EZH2 Targeted Therapy Market Research 2026: Ipsen Leads With Tazverik, Hengrui and Pfizer Advance Next-Generation EZH2 Programs - Opportunities, Approved Drug Prices, Sales, Clinical Trials Insights

Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "EZH2 Targeted Therapy Market Opportunity, Approved Drug Price, Sales and Clinical Trials Insight 2026" report has been added to ...
10. Dezember 2025 09:15 ET | Quelle: Research and Markets

China Leads Therapeutic Access with 74 Approved Immuno-Oncology Agents

Dublin, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: Immuno-oncology (2025)" has been added to ResearchAndMarkets.com's offering. The latest report delves into the dynamic...
05. November 2025 04:08 ET | Quelle: Research and Markets

Precision Oncology Research Report 2025: Market to Hit $158.9 Billion by 2029 as Genomics Diagnostics, Liquid Biopsies, Single-Cell Sequencing and Patient-Specific Cancer Vaccines Accelerate Adoption

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Precision Oncology Market Report 2025" report has been added to ResearchAndMarkets.com's offering.The precision oncology market size has grown rapidly...
22. September 2025 04:32 ET | Quelle: Research and Markets

Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024-2030: Advances in Next-Gen Immunotherapies, AI, and Biomarker-Driven Personalization are Driving Transformational Growth

Dublin, Sept. 22, 2025 (GLOBE NEWSWIRE) -- The "Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024-2030" report has been added to ResearchAndMarkets.com's offering. The revenue...

Nächste Seite